Clinical Trial Update: Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 study of belantamab mafodotin with cyclophosphamide and dexamethasone in relapsed/refractory multiple myeloma indicates the trial has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Blenrep (belantamab mafodotin)
• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Relapsed/Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-04-03